Fluticasone-Based versus Budesonide-Based Triple Therapies in COPD: Real-World Comparative Effectiveness and Safety
Sign Up to like & getrecommendations! Published in 2022 at "COPD: Journal of Chronic Obstructive Pulmonary Disease"
DOI: 10.1080/15412555.2022.2035705
Abstract: Abstract Triple therapy for chronic obstructive pulmonary disease (COPD) is recommended for some patients, but the inhaled corticosteroids (ICS) may differ in effectiveness and safety. We compared budesonide-based and fluticasone-based triple therapy given in two… read more here.
Keywords: based triple; budesonide based; triple therapy; therapy ... See more keywords
Hierarchical packing of racemic metallosupramolecular cages with Ni(II)-based triple-stranded helicate building blocks
Sign Up to like & getrecommendations! Published in 2023 at "IUCrJ"
DOI: 10.1107/s2052252523002385
Abstract: Racemic metallosupramolecular cages were fabricated from homochiral Ni(II)-based triple-stranded helicate building blocks. In hierarchical crystal packing, methyl groups of a cage can be accommodated in cone-shaped metal cluster metallocavitands of adjacent cages in the form… read more here.
Keywords: based triple; stranded helicate; racemic metallosupramolecular; helicate building ... See more keywords
Comparison of 10‐day levofloxacin bismuth‐based quadruple therapy and levofloxacin‐based triple therapy for Helicobacter pylori
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Digestive Diseases"
DOI: 10.1111/1751-2980.12498
Abstract: This was a prospective study aiming to investigate whether levofloxacin plus bismuth‐based quadruple therapy was more effective than levofloxacin‐based triple therapy after failed first‐line eradication therapies for Helicobacter pylori (H. pylori) infection. read more here.
Keywords: levofloxacin based; based triple; quadruple therapy; bismuth based ... See more keywords
Ultra‐deep sequencing analysis of resistance‐associated variants during retreatment with simeprevir‐based triple therapy after failure of telaprevir‐based triple therapy in patients with genotype 1 hepatitis C virus infection
Sign Up to like & getrecommendations! Published in 2017 at "Hepatology Research"
DOI: 10.1111/hepr.12817
Abstract: Simeprevir (SMV)‐based triple therapy is an effective retreatment option following failure of telaprevir (TVR)‐based triple therapy. However, it is unclear whether the persistence of resistance‐associated variants (RAVs) induced by TVR‐based therapy may reduce the treatment… read more here.
Keywords: based triple; triple therapy; associated variants; failure telaprevir ... See more keywords
A prospective evaluation of levofloxacin‐based triple therapy for refractory Helicobacter pylori infection in Australia
Sign Up to like & getrecommendations! Published in 2017 at "Internal Medicine Journal"
DOI: 10.1111/imj.13432
Abstract: First‐line Helicobacter pylori eradication failure is a common and challenging problem. read more here.
Keywords: levofloxacin based; based triple; prospective evaluation; helicobacter ... See more keywords
Comparative Efficacy of 14-Day Tegoprazan-Based Triple vs. 10-Day Tegoprazan-Based Concomitant Therapy for Helicobacter pylori Eradication
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Personalized Medicine"
DOI: 10.3390/jpm12111918
Abstract: Tegoprazan, a novel potassium-competitive acid blocker, is currently available for the treatment of Helicobacter pylori infection. We compared the efficacies of tegoprazan-based triple and concomitant therapies in a real-world practice. Data of patients treated with… read more here.
Keywords: based triple; concomitant therapy; therapy; day tegoprazan ... See more keywords
Is a Potassium-Competitive Acid Blocker Truly Superior to Proton Pump Inhibitors in Terms of Helicobacter pylori Eradication?
Sign Up to like & getrecommendations! Published in 2021 at "Gut and liver"
DOI: 10.5009/gnl20242
Abstract: Vonoprazan (VPZ), a new potassium-competitive acid blocker, has been approved and used for Helicobacter pylori eradication in Japan. To date, many studies, as well as several systematic reviews and meta-analyses (MAs), have compared VPZ-based 7-day… read more here.
Keywords: competitive acid; based triple; potassium competitive; triple therapy ... See more keywords
Efficacy and Tolerability of 14-Day Tegoprazan- versus Rabeprazole-Based Triple Therapy for Eradication of Helicobacter pylori: A Real-World Evidence Study.
Sign Up to like & getrecommendations! Published in 2022 at "Gut and liver"
DOI: 10.5009/gnl220218
Abstract: Background/Aims Tegoprazan, a new, fast, and strong potassium-competitive acid blocker, has been approved for the treatment of gastric acid-related diseases in Korea. However, real-world clinical data regarding this drug are scarce. We aimed to compare… read more here.
Keywords: based triple; rabeprazole based; triple therapy; therapy ... See more keywords
Ge-based triple-band infrared photodetector
Sign Up to like & getrecommendations! Published in 2018 at "Applied Physics Express"
DOI: 10.7567/apex.11.114102
Abstract: A triple-band infrared photodetector is developed by doping sulfur into germanium. The photocurrent spectrum at 20 K shows that there are three response bands at about 1.4, 1.6, and 6.5 µm, indicating the realization of… read more here.
Keywords: based triple; band infrared; band; infrared photodetector ... See more keywords